Watch CNBC’s full discussion with the ‘Squawk on the Street’ crew

CNBC’s Carl Quintanilla, Jim Cramer and David Faber discuss the news of the day. Got a confidential news tip? We want to hear ...

Cramer's mad dash: Revolution Medicines

CNBC's Jim Cramer and David Faber discuss Revolution Medicines' stock.

McCormick buys Unilever’s food business in deal that values it at nearly $45 billion

CNBC's David Faber reports on the latest on McCormick and Unilever.

Universal Music stock rises after Pershing Square’s $64 billion takeover proposal

CNBC's David Faber reports on the latest news around Universal Music. Got a confidential news tip? We want to hear from you.
CNBC

Faber Report: Trian and General Catalyst raise offer for Janus Henderson to $52 a share

CNBC's David Faber delivers his latest Faber Report. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to ...

SpaceX confidentially files for IPO, setting stage for record offering

Elon Musk's SpaceX is reportedly targeting a valuation of around $1.75 trillion in its forthcoming IPO.

Synopsys shares rise as activist Elliott builds multibillion-dollar stake in chip design firm

CNBC's David Faber and Jim Cramer discuss news on Elliot Investment Management building a big stake in chip-design software ...

Jefferies not interested in selling, sources say

CNBC's David Faber discusses the latest news surrounding Jefferies Financial.